首页> British journal of cancer> Phase II study of pemetrexed in combination with cisplatin in patients with advanced urothelial cancer: the PECULIAR study (KCSG 10-17).

Phase II study of pemetrexed in combination with cisplatin in patients with advanced urothelial cancer: the PECULIAR study (KCSG 10-17).

导出 OA

翻译打印收藏纠错

第一作者： Y J,Choi

第一单位： 1] Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea [2] Division of Hemato-oncology, Department of Internal Medicine, Korea University Anam Hospital, Seoul, Republic of Korea.

作者： Y J,Choi ^[1] ; S H,Lee ^[2] ; J-L,Lee ^[3] ; J-H,Ahn ^[3] ; K-H,Lee ^[4] ; D,You ^[5] ; B,Hong ^[5] ; J H,Hong ^[5] ; H,Ahn ^[5]

作者单位： 1] Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea [2] Division of Hemato-oncology, Department of Internal Medicine, Korea University Anam Hospital, Seoul, Republic of Korea. ^[1] Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea. ^[2] 1] Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea [2] Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. ^[3] Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. ^[4] Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. ^[5]